Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure

Heart

Volumn 89, Issue 6, 2003, Pages 621-624

  Bollano, E ^a   Täng, M Scharin ^a   Hjalmarson, A ^a   Waagstein, F ^a   Andersson, Bert ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; METOPROLOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPPLER ECHOCARDIOGRAPHY; DRUG RESPONSE; HEART EJECTION FRACTION; HEART FAILURE; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HUMAN; MEAN ARTERIAL PRESSURE; PRESSOR RESPONSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STRESS ECHOCARDIOGRAPHY;

EID: 0038664330     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.6.621     Document Type: Article

References (16)

1. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US carvedilol heart failure study group. N Engl J Med 1996;334:1349-55.
2. Trial Participants. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
3. Trial Participants. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999;353:2001-7.
4. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8.
5. Ruffolo RR. The pharmacology of dobutamine. Am J Med Sci 1987;294:244-8.
6. Sonnenblick EH, Frishman WH, LeJemtel TH. Dobutamine: a new synthetic cardioactive sympathetic amine. N Engl J Med 1979;300:17-22.
7. Schiller NB Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 1991;84(suppl 3):1280-7.
8. Vatner SF, McRitchie RJ, Braunwald E. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs. J Clin Invest 1974;53:1265-73.
9. Tarnow J, Komar K. Altered hemodynamic response to dobutamine in relation to the degree of preoperative beta-adrenoceptor blockade. Anesthesiology 1988;68:912-19.
10. Bristow MR. Beta-adrenergic receptor blockade in chronic heart failure. Circulation 2000;101:558-69.
11. Frishman WH. Carvedilol. N Engl J Med 1998;339:1759-65.
12. Gilbert EM, Abraham WT, Olsen S et al. Comparative hemodynamic left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation 1996;94:2817-25.
13. Bristow MR, Ginsburg R, Umans V, et al. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 1986;59:297-309.
14. Lindenfeld J, Lowes BD, Bristow MR. Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol. Ann Pharmacother 1999;33:1266-9.
15. Maack C, Elter T, Nickenig G, et al. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure. J Am Coll Cardiol 2001;38:939-46.
16. Metra M, Nodari S, Boldi E, et al. Differential effects of intravenous inotropes in patients on long-term beta-blocker therapy [abstract]. Eur Heart J 2000;21(suppl: August/September):298.